MX358827B - Supercóntigos de proteína basados en repeticiones de fibronectina tipo iii con superficies de unión alternativas. - Google Patents

Supercóntigos de proteína basados en repeticiones de fibronectina tipo iii con superficies de unión alternativas.

Info

Publication number
MX358827B
MX358827B MX2014003744A MX2014003744A MX358827B MX 358827 B MX358827 B MX 358827B MX 2014003744 A MX2014003744 A MX 2014003744A MX 2014003744 A MX2014003744 A MX 2014003744A MX 358827 B MX358827 B MX 358827B
Authority
MX
Mexico
Prior art keywords
protein scaffolds
type iii
fibronectin type
alternative binding
based protein
Prior art date
Application number
MX2014003744A
Other languages
English (en)
Other versions
MX2014003744A (es
Inventor
Steven Jacobs
Michael Diem
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MX2014003744A publication Critical patent/MX2014003744A/es
Publication of MX358827B publication Critical patent/MX358827B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Abstract

La presente invención se refiere a los supercóntigos de proteína y genotecas de supercóntigos basadas en una repetición defibronectina tipo III (FN3) con un diseño de superficie de unión alternativa, ácidos nucleicos aislados que codifican los supercóntigos de proteína, vectores, células huésped, y métodos para preparar los mismos son útiles en la generación de moléculas terapéuticas y en el tratamiento y diagnóstico de enfermedades y trastornos.
MX2014003744A 2011-09-27 2012-09-27 Supercóntigos de proteína basados en repeticiones de fibronectina tipo iii con superficies de unión alternativas. MX358827B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161539670P 2011-09-27 2011-09-27
PCT/US2012/057436 WO2013049275A1 (en) 2011-09-27 2012-09-27 Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces

Publications (2)

Publication Number Publication Date
MX2014003744A MX2014003744A (es) 2014-08-22
MX358827B true MX358827B (es) 2018-09-05

Family

ID=47911927

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003744A MX358827B (es) 2011-09-27 2012-09-27 Supercóntigos de proteína basados en repeticiones de fibronectina tipo iii con superficies de unión alternativas.

Country Status (13)

Country Link
US (3) US9200273B2 (es)
EP (3) EP4151785A1 (es)
JP (3) JP6440496B2 (es)
KR (2) KR102035713B1 (es)
CN (2) CN110725009B (es)
AU (2) AU2016269407A1 (es)
BR (1) BR112014007469B1 (es)
CA (1) CA2849774C (es)
EA (1) EA035150B1 (es)
ES (1) ES2928578T3 (es)
IL (3) IL277891B2 (es)
MX (1) MX358827B (es)
WO (1) WO2013049275A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060129246A (ko) 2003-12-05 2006-12-15 컴파운드 쎄라퓨틱스, 인크. 타입 2 혈관 내피 성장 인자 수용체의 억제제
KR20090110295A (ko) 2006-11-22 2009-10-21 에드넥서스, 어 브리스톨-마이어스 스퀴브 알＆디 컴파니 Ｉｇｆ-ｉｒ을 포함하는 티로신 키나제 수용체에 대한 공학처리된 단백질에 기반한 표적화 치료제
AU2009213141A1 (en) 2008-02-14 2009-08-20 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind EGFR
PE20091931A1 (es) 2008-05-22 2009-12-31 Bristol Myers Squibb Co Proteinas de dominio de armazon basadas en fibronectina multivalentes
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
WO2011150133A2 (en) 2010-05-26 2011-12-01 Bristol-Myers Squibb Company Fibronectin based scaffold proteins having improved stability
ES2942455T3 (es) 2011-04-13 2023-06-01 Bristol Myers Squibb Co Proteínas de fusión Fc que comprenden enlazadores o disposiciones nuevos
EP2709669A1 (en) 2011-05-17 2014-03-26 Bristol-Myers Squibb Company Methods for maintaining pegylation of polypeptides
US9522951B2 (en) 2011-10-31 2016-12-20 Bristol-Myers Squibb Company Fibronectin binding domains with reduced immunogenicity
EP3564258B1 (en) 2012-09-13 2021-04-28 Bristol-Myers Squibb Company Fibronectin based scaffold domain proteins that bind to myostatin
US9695228B2 (en) 2012-11-21 2017-07-04 Janssen Biotech, Inc. EGFR and c-Met fibronectin type III domain binding molecules
US20150361159A1 (en) 2013-02-01 2015-12-17 Bristol-Myers Squibb Company Fibronectin based scaffold proteins
WO2014124017A1 (en) 2013-02-06 2014-08-14 Bristol-Myers Squibb Company Fibronectin type iii domain proteins with enhanced solubility
EP3299378B1 (en) 2013-02-12 2019-07-31 Bristol-Myers Squibb Company High ph protein refolding methods
JP2017502002A (ja) 2013-12-09 2017-01-19 ニューヨーク・ユニバーシティ 抗ブドウ球菌剤の食細胞送達用組成物及び方法
KR102472862B1 (ko) 2014-03-20 2022-12-05 브리스톨-마이어스 스큅 컴퍼니 혈청 알부민-결합 피브로넥틴 유형 iii 도메인
WO2016014846A1 (en) 2014-07-23 2016-01-28 Moderna Therapeutics, Inc. Modified polynucleotides for the production of intrabodies
US11468969B2 (en) * 2014-11-26 2022-10-11 Biolojic Design Ltd. Computer assisted antibody re-epitoping
EP3985020A1 (en) 2015-04-24 2022-04-20 ViiV Healthcare UK (No.5) Limited Polypeptides targeting hiv fusion
EP3291836A4 (en) 2015-05-06 2018-11-14 Janssen Biotech, Inc. Prostate specific membrane antigen (psma) bispecific binding agents and uses thereof
EA201792441A2 (ru) 2015-05-06 2018-06-29 Янссен Байотек, Инк. Домены фибронектина типа iii, связывающиеся с простатспецифическим мембранным антигеном
JP6893504B2 (ja) 2015-09-23 2021-06-23 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 速い解離速度を有する血清アルブミン結合フィブロネクチンタイプｉｉｉドメイン
EP3463430A4 (en) 2016-06-03 2020-02-12 Janssen Biotech, Inc. SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
JP2019524721A (ja) * 2016-07-15 2019-09-05 ポセイダ セラピューティクス， インコーポレイテッド キメラ抗原受容体および使用方法
EP3484927A1 (en) * 2016-07-15 2019-05-22 Poseida Therapeutics, Inc. Chimeric antigen receptors (cars) specific for muc1 and methods for their use
CN109715199A (zh) * 2016-09-14 2019-05-03 詹森生物科技公司 包含bcma特异性iii型纤连蛋白结构域的嵌合抗原受体及其用途
EP3554535A4 (en) 2016-12-14 2020-10-21 Janssen Biotech, Inc. PD-L1 BINDING FIBRONECTIN TYPE III DOMAINS
JP7104703B2 (ja) * 2016-12-14 2022-07-21 ヤンセン バイオテツク，インコーポレーテツド Ｃｄ８ａ結合フィブロネクチンｉｉｉ型ドメイン
EP3554561B1 (en) 2016-12-14 2023-06-28 Janssen Biotech, Inc. Cd137 binding fibronectin type iii domains
WO2019040808A1 (en) * 2017-08-25 2019-02-28 Janssen Biotech, Inc. TYPE III FIBRONECTIN BINDER FCγRII DOMAINS, THEIR CONJUGATES AND MULTISPECIFIC MOLECULES COMPRISING THE SAME
EP3679145A2 (en) * 2017-09-08 2020-07-15 Poseida Therapeutics, Inc. Compositions and methods for chimeric ligand receptor (clr)-mediated conditional gene expression
AU2018386010A1 (en) * 2017-12-13 2020-05-14 Janssen Biotech, Inc. Immortalized car-T cells genetically modified to eliminate t-cell receptor and beta 2-microglobulin expression
JP6936276B2 (ja) 2019-04-23 2021-09-15 矢崎総業株式会社 車両用アンテナ
JP2022540843A (ja) 2019-07-12 2022-09-20 ヤンセン ファーマシューティカ エヌ．ベー． 結合剤及びその使用
WO2021076574A2 (en) 2019-10-14 2021-04-22 Aro Biotherapeutics Company Fn3 domain-sirna conjugates and uses thereof
WO2021076546A1 (en) 2019-10-14 2021-04-22 Aro Biotherapeutics Company Cd71 binding fibronectin type iii domains
WO2023249940A2 (en) * 2022-06-20 2023-12-28 Protelica, Inc. Fibronectin libraries for human therapeutic screening

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018030A (en) 1986-11-04 2000-01-25 Protein Polymer Technologies, Inc. Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0494955B1 (en) 1989-10-05 1998-07-15 Optein, Inc. Cell-free synthesis and isolation of novel genes and polypeptides
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
PT1696031E (pt) 1991-12-02 2010-06-25 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
EP0985039B1 (en) 1997-06-12 2008-02-20 Novartis International Pharmaceutical Ltd. Artificial antibody polypeptides
AU9393398A (en) 1997-09-16 1999-04-05 Egea Biosciences, Inc. Method for the complete chemical synthesis and assembly of genes and genomes
US6670127B2 (en) 1997-09-16 2003-12-30 Egea Biosciences, Inc. Method for assembly of a polynucleotide encoding a target polypeptide
US6846655B1 (en) 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
WO2000034784A1 (en) 1998-12-10 2000-06-15 Phylos, Inc. Protein scaffolds for antibody mimics and other binding proteins
US6472147B1 (en) 1999-05-25 2002-10-29 The Scripps Research Institute Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
EP1356075A4 (en) * 2000-10-16 2005-04-13 Compound Therapeutics Inc PROTEIN EQUIPMENT FOR ANTIBODY MIMETICS AND OTHER TIE PROTEINS
WO2004058821A2 (en) 2002-12-27 2004-07-15 Domantis Limited Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
GB0119476D0 (en) 2001-08-09 2001-10-03 Novartis Forschungsstiftlung Z Anti-tumour agents and method of identifying anti-tumour agents
JP4602614B2 (ja) 2001-09-26 2010-12-22 アイシン精機株式会社 自動車用ドア
AU2003243436A1 (en) 2002-06-06 2003-12-22 Shohei Koide Reconstituted polypeptides
KR101051245B1 (ko) 2002-09-06 2011-07-21 이소제니카 리미티드 시험관내 펩타이드 발현 라이브러리
AU2003275372A1 (en) 2002-09-30 2004-04-19 Compound Therapeutics, Inc. Methods of engineering spatially conserved motifs in polypeptides
US20080220049A1 (en) 2003-12-05 2008-09-11 Adnexus, A Bristol-Myers Squibb R&D Company Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
KR20060129246A (ko) 2003-12-05 2006-12-15 컴파운드 쎄라퓨틱스, 인크. 타입 2 혈관 내피 성장 인자 수용체의 억제제
US20060040278A1 (en) 2004-01-27 2006-02-23 Cojocaru Gad S Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer
EA200801515A1 (ru) 2006-01-24 2009-02-27 Домантис Лимитед Лиганды, которые связывают il-4 и/или il-13
SG134283A1 (en) 2006-01-24 2007-08-29 Ind Tech Res Inst Biomarkers for liver fibrotic injury
US8536113B2 (en) 2006-12-21 2013-09-17 Janssen Biotech, Inc. EGFR binding peptides and uses thereof
US20110009323A1 (en) 2007-06-15 2011-01-13 Vasgene Therapeutics, Inc. Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth
US8470966B2 (en) * 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
JP5781762B2 (ja) * 2007-08-10 2015-09-24 プロテリックス、インク ユニバーサルｉｉｉ型フィブロネクチン結合ドメインのライブラリ
KR101686247B1 (ko) 2007-10-31 2016-12-14 메디뮨 엘엘씨 단백질 스캐폴드
AU2008343589A1 (en) 2007-12-19 2009-07-09 Centocor Ortho Biotech Inc. Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods
AU2008343595A1 (en) 2007-12-19 2009-07-09 Centocor Ortho Biotech Inc. A human non-antibody peptide or protein phage library
WO2009086116A2 (en) 2007-12-19 2009-07-09 Centocor, Inc. Alternative scaffold protein fusions phage display via fusion to plx of m13 phage
PT2274331E (pt) 2008-05-02 2014-02-27 Novartis Ag Moléculas de ligação baseadas em fibronectina melhoradas e suas utilizações
EP2349327A4 (en) * 2008-10-23 2012-11-28 Massachusetts Inst Technology COMMITMENT DIRECTED FC RECEIVERS ACTIVATORS
US8415291B2 (en) 2008-10-31 2013-04-09 Centocor Ortho Biotech Inc. Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses
MX2011004550A (es) * 2008-10-31 2011-07-20 Centocor Ortho Biotech Inc Composiciones de de supercóntigos a base de dominios de fibronectina tipo iii, métodos y usos.
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
WO2010093627A2 (en) 2009-02-12 2010-08-19 Centocor Ortho Biotech Inc. Fibronectin type iii domain based scaffold compositions, methods and uses
EP2452165A1 (en) 2009-07-07 2012-05-16 Siemens AG Apparatus and method for measuring multi-phase fluid flow
MX339126B (es) 2010-04-30 2016-05-11 Janssen Biotech Inc Composiciones de dominio de fibronectina estabilizadas, metodos y usos.
WO2012016245A2 (en) 2010-07-30 2012-02-02 Novartis Ag Fibronectin cradle molecules and libraries thereof

Also Published As

Publication number Publication date
KR102142385B1 (ko) 2020-08-10
AU2018204514A1 (en) 2018-07-12
EP4151785A1 (en) 2023-03-22
CN110725009A (zh) 2020-01-24
US9897612B2 (en) 2018-02-20
CN103827361A (zh) 2014-05-28
CA2849774A1 (en) 2013-04-04
JP2019081760A (ja) 2019-05-30
JP6722263B2 (ja) 2020-07-15
EP3540100B8 (en) 2022-11-02
BR112014007469A2 (pt) 2017-04-04
MX2014003744A (es) 2014-08-22
US20160041182A1 (en) 2016-02-11
JP6445600B2 (ja) 2018-12-26
AU2012316080B2 (en) 2016-09-01
EP3540100B1 (en) 2022-08-17
EP2761066A4 (en) 2015-06-17
AU2012316080A8 (en) 2016-09-08
EP2761066B1 (en) 2018-12-05
EA201490703A1 (ru) 2014-09-30
CN110725009B (zh) 2024-01-30
US10571472B2 (en) 2020-02-25
KR102035713B1 (ko) 2019-10-24
IL277891A (en) 2020-11-30
KR20190121412A (ko) 2019-10-25
JP2014530014A (ja) 2014-11-17
IL277891B1 (en) 2023-09-01
AU2012316080A1 (en) 2014-04-03
WO2013049275A1 (en) 2013-04-04
IL277891B2 (en) 2024-01-01
IL269470A (en) 2019-11-28
AU2016269407A1 (en) 2016-12-22
JP6440496B2 (ja) 2018-12-19
BR112014007469B1 (pt) 2022-06-14
KR20140069226A (ko) 2014-06-09
AU2018204514B2 (en) 2020-06-18
IL231585B (en) 2019-09-26
US20130079243A1 (en) 2013-03-28
US9200273B2 (en) 2015-12-01
US20180143203A1 (en) 2018-05-24
JP2017121238A (ja) 2017-07-13
EP2761066A1 (en) 2014-08-06
CA2849774C (en) 2020-01-07
ES2928578T3 (es) 2022-11-21
EP3540100A1 (en) 2019-09-18
IL231585A0 (en) 2014-05-28
EA035150B1 (ru) 2020-05-06

Similar Documents

Publication Publication Date Title
MX2014003744A (es) Supercóntigos de proteina basados en repeticiones de fibronectina tipo iii con superficies de union alternativas.
EA201590488A1 (ru) Способы модификации клеток-хозяев
EA201792441A2 (ru) Домены фибронектина типа iii, связывающиеся с простатспецифическим мембранным антигеном
MY176820A (en) Egfr and c-met fibronectin type iii domain binding molecules
MX2013007997A (es) Polipeptidos que tienen actividad de incremento celulolitico y polinucleotidos que codifican para los mismos.
MX2019002498A (es) Metodos y productos para la expresion de proteinas en celulas.
WO2012094492A3 (en) Combinatorial dna taggants and methods of preparation and use thereof
MX2020006065A (es) Metodos y productos para la produccion y administracion de acido nucleico.
MX2021000210A (es) Metodos y productos para transfeccion de celulas.
MX2013007853A (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
WO2010093627A3 (en) Fibronectin type iii domain based scaffold compositions, methods and uses
MX337919B (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
MX353621B (es) Variantes de alfa-amilasa.
WO2014106107A3 (en) Dhad variants for butanol production
MX337913B (es) Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos.
EP2274442A4 (en) CONSENSUS SEQUENCES OF CHIKUNGUNYA VIRUS PROTEINS, NUCLEIC ACID MOLECULES ENCODING SAME, AND COMPOSITIONS AND METHODS OF USE THEREOF
MX2014001383A (es) Colageno 7 y metodos relacionados.
AR072531A1 (es) SENAL DE POLIADENILACIoN
MX2015000312A (es) Polipeptidos que tienen actividad lipasa y polinucleotidos que los codifican.
WO2016049364A3 (en) Tyrosine hydroxylase variants and methods of use thereof
HK1143404A1 (en) Cell for use in the production of exogenous protein, and production process using the cell
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
EA201000273A1 (ru) Белок-предшественник тиопептида, кодирующий его ген и его применение
MX350391B (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.
WO2012122378A3 (en) Antibody-like proteins for therapeutic and diagnostic use

Legal Events

Date Code Title Description
FG Grant or registration